CenterBook Partners’s Meridian Bioscience Inc VIVO Stock Holding History

CenterBook Partners’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,840	Closed	-$426K	–	484
2022 Q4	$426K	Buy	+12,840	New	+$414K	0.07%	299

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CenterBook Partners's VIVO Position: Q1 2023 in Review

CenterBook Partners sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 12,840 shares — an estimated $426K sold.

CenterBook Partners first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $426K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

CenterBook Partners reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
CenterBook Partners sold 12,840 Meridian Bioscience Inc shares in Q1 2023, an estimated $426K.
CenterBook Partners first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
CenterBook Partners's Meridian Bioscience Inc position peaked at $426K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on CenterBook Partners's 13F filing for Q1 2023, filed 15 May 2023.